Clinical trial of selpercatinib shows strong response for patients with non-small cell lung cancer
An international team of researchers has found that selpercatinib, a drug that precisely targets cancers driven by mutations or alterations
Read moreAn international team of researchers has found that selpercatinib, a drug that precisely targets cancers driven by mutations or alterations
Read more